Who We Are
We are a non-profit association based in Sabadell, Spain, made up of a group of volunteers brought together by the common interest in battling leukemia with open-source technologies and open information.
We bring together individuals, companies and organizations to create innovative technologies that can be used in the fight against leukemia and other cancers, and to help bring down the cost of treatment for patients. We are building a network of innovation and collaboration to provide a better future for people and society.
What We Do
- We create open-source technologies related to the research and detection of Leukemia and other cancers, identifying potential candidates for drugs that can help in the fight against cancer, and to improve efficiency of health and medical organizations, with the goals of reducing the costs of the services they provide to patients.
- We create open-source technologies for medical use cases including networks, devices and applications.
- We provide a free student program, Peter Moss Leukemia AI Research Student Program, providing students with an opportunity to learn about Artificial Intelligence and other technologies and their use in medical applications for diagnosis and drug discovery.
- We provide open information for families, carers, researchers, programmers, students.
Our mission, since 2018, is to advance Leukemia medical research using the latest technologies such as Artificial Intelligence, Internet of Things, Robotics, Virtual/Augmented/Mixed Reality, 3D Design & Printing and Blockchain. We aim to ensure our research, findings, and technologies remain free to anyone that can benefit from their use, whether personal, educational or commercial.
We are creating an "open source" movement for leukemia research and medical technologies. No patents, no proprietary data, no proprietary code. We want to give our tech and our research, to the people!
How We Began
In 2018 the grandfather of Association President, Adam Milton-Barker, was diagnosed terminally ill with Acute Myeloid Leukemia. One month before he was diagnosed he had an all clear blood test, with no signs of Acute Myeloid Leukemia, Adam was convinced that there must have been signs in that blood test that could have given a clue to what was coming the following month.
Adam had previous experience with using Artificial Intelligence for breast cancer detection through the Breast Cancer AI project, and wanted to see this experience could be used to help with Acute Myeloid Leukemia.
Adam created the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project, and set out to build a team that would work on open-source classifiers for Leukemia.